Albert Yeung Net Worth

The estimated Net Worth of Albert Yeung is at least $7.76 Million dollars as of 9 December 2016. Albert Yeung owns over 25,000 units of China Biologic Products Inc stock worth over $7,758,900 and over the last 12 years Albert sold CBPO stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Albert Yeung CBPO stock SEC Form 4 insiders trading

Albert has made over 1 trades of the China Biologic Products Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Albert exercised 25,000 units of CBPO stock worth $260,750 on 9 December 2016.

The largest trade Albert's ever made was exercising 25,000 units of China Biologic Products Inc stock on 9 December 2016 worth over $260,750. On average, Albert trades about 3,571 units every 0 days since 2012. As of 9 December 2016 Albert still owns at least 45,000 units of China Biologic Products Inc stock.

You can see the complete history of Albert Yeung stock trades at the bottom of the page.

Insiders trading at China Biologic Products Inc

Over the last 17 years, insiders at China Biologic Products Inc have traded over $4,633,340,868 worth of China Biologic Products Inc stock and bought 6,331,200 units worth $103,519,340 . The most active insiders traders include Pincus Private Equity X, L...., X Biologics Llc Warburg Pin..., and X Biologics Llckaye Charles.... On average, China Biologic Products Inc executives and independent directors trade stock every 38 days with the average trade being worth of $126,850,084. The most recent stock trade was executed by Zhijing Cbpo Liu on 8 May 2017, trading 7,500 units of CBPO stock currently worth $73,875.

What does China Biologic Products Inc do?

Complete history of Albert Yeung stock trades at China Biologic Products Inc

China Biologic Products Inc executives and stock owners

China Biologic Products Inc executives and other stock owners filed with the SEC include:

• Ming Yang,
  Chief Financial Officer
• Xiaosheng Shao,
  Independent Director
• Qi Ning,
  Independent Director
• Yungang Lu,
  Independent Director
• Yue'e Zhang,
  Director
• Hui Li,
  Director
• Joseph Chow,
  Chairman of the Board, Chief Executive Officer
• Albert Yeung,
  Director
• Gang Cbpo Yang,
  Corporate Vice President
• Zhijun Tong,
  Director
• Min Fang,
  Director
• Zhijing Cbpo Liu,
  Corporate Vice President
• David Gao,
  Chief Executive Officer
• Wenfang Liu,
  Director
• X Biologics Llckaye Charles...,
  
• Sean Shao,
  Director
• X Biologics Llc Warburg Pin...,
  
• Ming Yin,
  Senior Corporate VP
• Le Zhang,
  Director
• Bing Li,
  Director
• X Biologics Llc Warburg Pin...,
  
• Pincus Private Equity X, L....,
  
• Lin Ling Li,
  Director
• Chao Ming Zhao,
  Chief Financial Officer
• Ling Siu Chan,
  Director
• Yuyun Tristan Kuo,
  Chief Financial Officer
• Barry M Kitt,
  10% owner
• Tong Jun Lin,
  Director
• Xiangmin Cui,
  Director
• Pincus Private Equity X, L....,
  
• Cbpo Stanley Wong,
  Chief Executive Officer